BDBM50166551 CHEMBL194173::N*2*-[1-(4-Bromo-2-trifluoromethoxy-benzenesulfonyl)-piperidin-4-ylmethyl]-N*4*,N*4*-dimethyl-quinazoline-2,4-diamine

SMILES CN(C)c1nc(NCC2CCN(CC2)S(=O)(=O)c2ccc(Br)cc2OC(F)(F)F)nc2ccccc12

InChI Key InChIKey=UHHJLMKELWKRFM-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50166551   

TargetNeuropeptide Y receptor type 5(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50166551(N*2*-[1-(4-Bromo-2-trifluoromethoxy-benzenesulfony...)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMelanin-concentrating hormone receptor 1(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50166551(N*2*-[1-(4-Bromo-2-trifluoromethoxy-benzenesulfony...)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibitory activity against mutated constitutively activated human Melanin concentrating hormone receptor 1 (CA-MCH-R1) stably expressed in HEK293 ce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAlpha-2A adrenergic receptor(Human)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50166551(N*2*-[1-(4-Bromo-2-trifluoromethoxy-benzenesulfony...)
Affinity DataIC50: 5.60nMAssay Description:Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed